Table of Content

1. Introduction


2. Research& Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Anti-Venom Market


6. Market Share – Global Anti-Venom Analysis

6.1 Type
6.2 Animal Type
6.3 End Users
6.4 Country


7. Type – Global Anti-Venom Market

7.1 Polyvalent Anti-Venom
7.2 Monovalent Anti-Venom


8. Animal Type – Global Anti-Venom Market

8.1 Snake
8.2 Scorpion
8.3 Spider
8.4 Others


9. End Users – Global Anti-Venom Market

9.1 Clinics
9.2 Hospitals
9.3 Ambulatory Surgical Centers
9.4 Others


10. Country – Global Anti-Venom Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis – Global Anti-Venom Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Anti-Venom Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players

13.1 Bharat Serums and Vaccines Limited (BSV)

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 Boehringer Ingelheim International GmbH

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Boston Scientific Corporation

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue

13.4 CSL Limited

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 Merck & Co. Inc.

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue

13.6 Merck KGaA

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue

13.7 Pfizer Inc.

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue

13.8 Haffkine Bio-Pharmaceutical Corporation Limited

13.8.1 Overview
13.8.2 Recent Development



List of Figures

Figure-01: Global – Anti-Venom Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Anti-Venom Market (Billion US$), 2024 – 2032
Figure-03: Type – Polyvalent Anti-Venom Market (Million US$), 2019 – 2023
Figure-04: Type – Forecast for Polyvalent Anti-Venom Market (Million US$), 2024 – 2032
Figure-05: Type – Monovalent Anti-Venom Market (Million US$), 2019 – 2023
Figure-06: Type – Forecast for Monovalent Anti-Venom Market (Million US$), 2024 – 2032
Figure-07: Animal Type – Snake Market (Million US$), 2019 – 2023
Figure-08: Animal Type – Forecast for Snake Market (Million US$), 2024 – 2032
Figure-09: Animal Type – Scorpion Market (Million US$), 2019 – 2023
Figure-10: Animal Type – Forecast for Scorpion Market (Million US$), 2024 – 2032
Figure-11: Animal Type – Spider Market (Million US$), 2019 – 2023
Figure-12: Animal Type – Forecast for Spider Market (Million US$), 2024 – 2032
Figure-13: Animal Type – Others Market (Million US$), 2019 – 2023
Figure-14: Animal Type – Forecast for Others Market (Million US$), 2024 – 2032
Figure-15: End Users – Clinics Market (Million US$), 2019 – 2023
Figure-16: End Users – Forecast for Clinics Market (Million US$), 2024 – 2032
Figure-17: End Users – Hospitals Market (Million US$), 2019 – 2023
Figure-18: End Users – Forecast for Hospitals Market (Million US$), 2024 – 2032
Figure-19: End Users – Ambulatory Surgical Centers Market (Million US$), 2019 – 2023
Figure-20: End Users – Forecast for Ambulatory Surgical Centers Market (Million US$), 2024 – 2032
Figure-21: End Users – Others Market (Million US$), 2019 – 2023
Figure-22: End Users – Forecast for Others Market (Million US$), 2024 – 2032
Figure-23: United States – Anti-Venom Market (Million US$), 2019 – 2023
Figure-24: United States – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-25: Canada – Anti-Venom Market (Million US$), 2019 – 2023
Figure-26: Canada – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-27: France – Anti-Venom Market (Million US$), 2019 – 2023
Figure-28: France – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-29: Germany – Anti-Venom Market (Million US$), 2019 – 2023
Figure-30: Germany – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-31: Italy – Anti-Venom Market (Million US$), 2019 – 2023
Figure-32: Italy – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-33: Spain – Anti-Venom Market (Million US$), 2019 – 2023
Figure-34: Spain – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-35: United Kingdom – Anti-Venom Market (Million US$), 2019 – 2023
Figure-36: United Kingdom – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-37: Belgium – Anti-Venom Market (Million US$), 2019 – 2023
Figure-38: Belgium – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-39: Netherlands – Anti-Venom Market (Million US$), 2019 – 2023
Figure-40: Netherlands – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-41: Turkey – Anti-Venom Market (Million US$), 2019 – 2023
Figure-42: Turkey – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-43: China – Anti-Venom Market (Million US$), 2019 – 2023
Figure-44: China – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-45: Japan – Anti-Venom Market (Million US$), 2019 – 2023
Figure-46: Japan – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-47: India – Anti-Venom Market (Million US$), 2019 – 2023
Figure-48: India – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-49: South Korea – Anti-Venom Market (Million US$), 2019 – 2023
Figure-50: South Korea – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-51: Thailand – Anti-Venom Market (Million US$), 2019 – 2023
Figure-52: Thailand – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-53: Malaysia – Anti-Venom Market (Million US$), 2019 – 2023
Figure-54: Malaysia – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-55: Indonesia – Anti-Venom Market (Million US$), 2019 – 2023
Figure-56: Indonesia – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-57: Australia – Anti-Venom Market (Million US$), 2019 – 2023
Figure-58: Australia – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-59: New Zealand – Anti-Venom Market (Million US$), 2019 – 2023
Figure-60: New Zealand – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-61: Brazil – Anti-Venom Market (Million US$), 2019 – 2023
Figure-62: Brazil – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-63: Mexico – Anti-Venom Market (Million US$), 2019 – 2023
Figure-64: Mexico – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-65: Argentina – Anti-Venom Market (Million US$), 2019 – 2023
Figure-66: Argentina – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-67: Saudi Arabia – Anti-Venom Market (Million US$), 2019 – 2023
Figure-68: Saudi Arabia – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-69: UAE – Anti-Venom Market (Million US$), 2019 – 2023
Figure-70: UAE – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-71: South Africa – Anti-Venom Market (Million US$), 2019 – 2023
Figure-72: South Africa – Forecast for Anti-Venom Market (Million US$), 2024 – 2032
Figure-73: Bharat Serums and Vaccines Limited (BSV) – Global Revenue Market (Million US$), 2019 – 2023
Figure-74: Bharat Serums and Vaccines Limited (BSV) – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-75: Boehringer Ingelheim International GmbH – Global Revenue Market (Million US$), 2019 – 2023
Figure-76: Boehringer Ingelheim International GmbH – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-77: Boston Scientific Corporation – Global Revenue Market (Million US$), 2019 – 2023
Figure-78: Boston Scientific Corporation – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-79: CSL Limited – Global Revenue Market (Million US$), 2019 – 2023
Figure-80: CSL Limited – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-81: Merck & Co. Inc. – Global Revenue Market (Million US$), 2019 – 2023
Figure-82: Merck & Co. Inc. – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-83: Merck KGaA – Global Revenue Market (Million US$), 2019 – 2023
Figure-84: Merck KGaA – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-85: Pfizer Inc. – Global Revenue Market (Million US$), 2019 – 2023
Figure-86: Pfizer Inc. – Forecast for Global Revenue Market (Million US$), 2024 – 2032

List of Tables

Table-01: Global – Anti-Venom Market Share by Type (Percent), 2019 – 2023
Table-02: Global – Forecast for Anti-Venom Market Share by Type (Percent), 2024 – 2032
Table-03: Global – Anti-Venom Market Share by Animal Type (Percent), 2019 – 2023
Table-04: Global – Forecast for Anti-Venom Market Share by Animal Type (Percent), 2024 – 2032
Table-05: Global – Anti-Venom Market Share by End User (Percent), 2019 – 2023
Table-06: Global – Forecast for Anti-Venom Market Share by End User (Percent), 2024 – 2032
Table-07: Global – Anti-Venom Market Share by Countries (Percent), 2019 – 2023
Table-08: Global – Forecast for Anti-Venom Market Share by Countries (Percent), 2024 – 2032